Autoantibodies in connective tissue disease

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Autoimmune connective tissue diseases (ACTDs) are complex rheumatic conditions impacting multiple organ systems.
• Autoantibodies are key diagnostic markers in ACTDs, often correlating with specific clinical manifestations.
• These autoantibodies are crucial for understanding disease progression and patient outcomes.

Purpose of the Study:

• To review autoantibodies associated with ACTDs, excluding systemic lupus erythematosus.
• To correlate autoantibody identification with clinical features, prognosis, and management strategies.
• To discuss practical aspects and challenges in autoantibody testing.

Main Methods:

• Literature review focusing on autoantibodies in ACTDs (excluding SLE).
• Analysis of established associations between autoantibodies and clinical complications.
• Discussion of diagnostic utility, prognostic value, and therapeutic implications.

Main Results:

• Specific autoantibodies are linked to distinct clinical features and organ involvement in ACTDs.
• Identification of autoantibodies aids in predicting disease course and guiding treatment decisions.
• Practical considerations for autoantibody testing reveal potential diagnostic pitfalls.

Conclusions:

• Autoantibodies are vital biomarkers in ACTDs, offering diagnostic and prognostic insights.
• Understanding autoantibody profiles is essential for personalized patient management.
• Accurate autoantibody testing and interpretation are critical for optimal clinical care.